Teva swings to net, led by Copaxone, new launches
February 16, 2010 at 06:41 AM EST
Teva Pharmaceutical Industries Ltd. swings to a profit in the fourth quarter led by strength in its flagship multiple-sclerosis medication.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.